Welcome to our dedicated page for SS Innovations news (Ticker: SSII), a resource for investors and traders seeking the latest updates and insights on SS Innovations stock.
SS Innovations International Inc. develops and commercializes surgical robotic technologies centered on the SSi Mantra Surgical Robotic System, a modular multi-arm platform used across multiple surgical specialties. Company news commonly covers SSi Mantra procedure milestones, global system installations, telesurgery demonstrations, regulatory approvals in international markets, and financial results tied to installations, procedures and revenue.
Updates also address the company’s surgical robotics ecosystem, including the SSi MantrAsana tele-surgeon console, the MantraM mobile robotic telesurgery unit, SSi Mudra instrumentation, and development-stage concepts such as SSi Vimana Aero, SSi Avtara and SSi Operion. Capital actions, Nasdaq trading status and company-hosted robotic surgery conferences are additional recurring themes.
SS Innovations (NASDAQ: SSII) announced that its SSi Mantra surgical robotic system will be showcased at the Society of Robotic Surgery Annual Meeting (SRS 2026) in Hollywood, Florida, on July 23–26, 2026. The system will be displayed, highlighted in multiple breakout sessions, and used in a live-broadcast kidney telesurgery (partial nephrectomy) performed remotely from Gurugram, India, on a patient in New Delhi.
Chairman and CEO Dr. Sudhir Srivastava will speak or serve as panelist in several sessions covering telesurgery, global access, soft-tissue robotics, regulatory frameworks, industry perspectives, and global/military applications. As of July 6, 2026, the SSi Mantra has been used in 12,375 procedures, including 653 cardiac, 178 telesurgeries, and 225 pediatric surgeries, with about 2,100 physicians trained across more than 170 procedure types.
SS Innovations (Nasdaq: SSII) has appointed veteran medtech finance executive Sarah M. Romano as Chief Financial Officer, effective August 3, 2026. She will be based in the United States and is expected to support the company’s next phase of global growth.
According to SS Innovations, Romano brings over 20 years of financial leadership in medical technology and life sciences, including CFO roles at Vicarious Surgical, Entero Therapeutics and Kiora Pharmaceuticals, where she led capital strategy, strategic transactions and SEC reporting, and helped raise more than $100 million through public and private financings.
SS Innovations (NASDAQ: SSII) announced that subsidiary SS International Centre for Robotics Surgery (SSICRS) has graduated its first Cardiac Robotic Surgery Training class at its Gurugram, India headquarters.
The inaugural five-day course trained 33 participants from seven countries using the SSi Mantra surgical robotic system with live demos, hands-on labs, and virtual sessions.
SS Innovations (NASDAQ: SSII) was named the Outstanding Company winner at the 2026 Surgical Robotics Industry Awards, recognizing leadership in surgical robotics and impact on access to care.
As of June 22, 2026, the SSi Mantra has supported 11,719 multi-specialty procedures, including 612 cardiac, 175 telesurgeries, and 212 pediatric cases. About 2,100 physicians have been trained, using the system for 170+ procedure types. The platform has regulatory approval in 14 countries, including India, Indonesia, Kenya, UAE, and others.
SS Innovations (Nasdaq: SSII) reported completion of the world’s longest-distance robotic telesurgery, using its SSi Mantra system over about 12,500 miles (20,000 km) between Guyana and India for a cardiac LIMA takedown.
The company notes 173 total telesurgeries and 22 cardiac telesurgeries completed with SSi Mantra, which has regulatory approval in 14 countries, including recent approval in Guyana.
SS Innovations (Nasdaq: SSII) reported record Q1 2026 revenue of $11.1 million, up 116.8% year over year. Gross margin rose to 48.0% and gross profit reached $5.3 million. Net loss narrowed to $3.6 million ($0.02/share). The SSi Mantra installed base grew to 194 systems across eleven countries with 9,744 cumulative surgeries. Cash and cash equivalents were $16.0 million with no long-term debt. The company raised $18.6 million in a March 2026 private placement and gained new regulatory approvals for SSi Mantra in Sri Lanka, Kenya, Indonesia, and the Philippines.
SS Innovations (Nasdaq: SSII) announced a successful long-distance cross-border telesurgery on May 2, 2026, connecting a surgeon in Perth, Australia to a patient in Indore, India, spanning more than 4,500 miles. The procedure used the SSi Mantra surgical robot and the portable SSi MantrAsana tele-surgeon console.
According to the company, the MantrAsana supports ultra-low latency connectivity, high-definition visualization, and precise instrument control; SS Innovations says the SSi Mantra platform has been used in more than 170 telesurgeries to date.
SS Innovations (Nasdaq: SSII) announced that more than 10,500 cumulative surgeries have been performed using its SSi Mantra surgical robotic system as of April 30, 2026. The tally includes >500 cardiac procedures, 170 telesurgeries, 125 pediatric surgeries, ~2,100 trained physicians, and an installed base of >200 systems across 11 countries.
The milestone highlights multi-specialty adoption and training scale since the SSi Mantra commercial launch in August 2022.
SS Innovations (Nasdaq: SSII) unveiled multiple surgical robotic concepts at SMRSC 2026 on April 23, 2026, in New Delhi, including the SSi Vimana Aero drone-delivered surgical system, SSi Avtara humanoid platform, SSi Operion mobile operating room, and single-arm endoscopy/ultrasound assist carts.
SMRSC 2026 drew over 1,600 onsite and 1,800 virtual attendees; the company demonstrated the SSi Mantra with 10 live telesurgeries and 13 live robotic surgeries. Single-arm carts are in early clinical validation in India.
SS Innovations (Nasdaq: SSII) will host the Global Multi-Specialty Robotic Surgery Conference, SMRSC 2026, in New Delhi, India from April 9-11, 2026. The event features live telesurgeries, the SSi MantrAsana tele surgeon console, the SSi Vimana Aero drone trauma system, Project Operion and the MantraM mobile unit.
The conference aims to showcase multispecialty robotic demos, training, telesurgery protocols and innovations that support decentralized access to robotic surgical care.